Sage Therapeutics Inc.

In News

Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - Yahoo Finance

Yahoo Finance - Sep 02, 2025

Former Sage Therapeutics executives launch neurology biotech with $106M - The Business Journals

The Business Journals - Apr 21, 2026

Supernus completes acquisition of Sage Therapeutics for $8.50 per share - Investing.com

Investing.com - Jul 31, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics - TMX Newsfile

TMX Newsfile - May 02, 2026

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics - GlobeNewswire

GlobeNewswire - Jul 31, 2025

Sage lays off entire staff of 338 amid takeover by Supernus - Fierce Pharma

Fierce Pharma - Jun 30, 2025

Sage, following setbacks, to sell to Supernus for $561M - BioPharma Dive

BioPharma Dive - Jun 16, 2025

After brushing off Biogen, Mass. biotech firm finds buyer for $795M - NBC Boston

NBC Boston - Jun 16, 2025

Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supernus - BioSpace

BioSpace - Jun 16, 2025

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression - Biogen

Biogen - Jul 25, 2025

SAGE Therapeutics Announces Nasdaq Delisting After Merger - TipRanks

TipRanks - Jul 31, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics - TMX Newsfile

TMX Newsfile - Apr 30, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment